Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001405626-18-000005)

Filing Details

Accession Number:: 0001405626-18-000005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-02 17:15:27
Reporting Period:: 2018-06-28

Accepted Time:: 2018-07-02 17:15:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596062	Q Biomed Inc.	QBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1405626	Denis Corin	10 Market Street Suite 427 Grand Cayman E9 KY1-9006	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-06-28	5,300	$3.39	2,475,600	No	4	S	Direct
Common Stock	Disposition	2018-06-29	2,100	$3.40	2,473,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2018 for the sale of up to 139,871 shares of common stock. Such sales were outside the Reporting Person's investment decision.